Arvinas, Inc. (ARVN) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-24 17:37:55 ET
Arvinas, Inc. (ARVN) Q4 2025 Earnings Call February 24, 2026 8:00 AM EST
Company Participants
Jeff Boyle - Vice President of Investor Relations
Randy Teel - CEO, President & Director
Noah Berkowitz - Chief Medical Officer
Angela Cacace - Chief Scientific Officer
Andrew Saik - CFO & Treasurer
...
Read the full article on Seeking Alpha
For further details see:
Arvinas, Inc. (ARVN) Q4 2025 Earnings Call Transcript
Arvinas Inc.
NASDAQ: ARVN
ARVN Trading
1.4% G/L:
$13.37 Last:
292,792 Volume:
$13.07 Open:
ARVN Latest News
February 24, 2026 07:00:00 am
Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
ARVN Stock Data
$861,247,783
61,186,485
0.05%
68
N/A
Biotechnology & Life Sciences
Healthcare
US
New Haven
